PharmaBharatPharma & Life Sciences Jobs
Menu

WhatsApp GroupJoinWhatsApp ChannelJoinTelegram GroupJoin
---Advertisement---

Pharmacovigilance Jobs in Noida – Apply Now at Jubilant Pharma

Published on

Executive - Pharmacovigilance

Jubilant Generics Limited

Jubilant Generics Limited logo

Bachelor’s/Master’s in Pharmacy, Life Sciences, or related field

Greater Noida, Uttar Pradesh

3 - 8 years

Verified Job

Online Application

Jubilant Generics Limited (JGL) is a wholly-owned subsidiary of Jubilant Pharma Limited, a global integrated pharmaceutical company. With a strong presence in Specialty Pharmaceuticals, Generics, and APIs, Jubilant serves customers worldwide.

Job Highlights

✔ Experience Required: 3+ years in the pharmaceutical industry
✔ Key Skills: Regulatory affairs, clinical data management, ICH-GCP compliance
✔ Role: Manage regulatory submissions, ensure pharmacovigilance compliance
✔ Location: Greater Noida (USFDA-approved facilities)

Job Description: Executive – Pharmacovigilance

Key Responsibilities:

  • Ensure compliance with ICH-GCP, GVP, and global pharmacovigilance regulations
  • Manage regulatory submissions for drug safety and adverse event reporting
  • Collaborate with cross-functional teams for clinical data management
  • Prepare and review Periodic Safety Update Reports (PSURs), PADER, and DSURs
  • Conduct signal detection and risk management activities
  • Maintain pharmacovigilance databases and ensure timely reporting to health authorities

Required Skills & Qualifications:

  • Bachelor’s/Master’s in Pharmacy, Life Sciences, or related field
  • 3+ years in pharmacovigilance, regulatory affairs, or drug safety
  • Strong knowledge of MedDRA, WHO-DD, and Argus/Safety Databases
  • Experience with USFDA, EMA, and other global regulatory guidelines
  • Excellent communication and analytical skills

How to Apply?

Application Link

---Advertisement---
---Advertisement---

Share this job

✅ Copied!

Looking for more opportunities?

Browse latest jobs →
Follow PharmaBharat on Google